[NH2:1][C:2]1[CH:3]=[C:4]([CH:10]=[C:11]([C:13]([F:16])([F:15])[F:14])[CH:12]=1)[C:5]([N:7]([CH3:9])[CH3:8])=O.B.C1COCC1>C1COCC1>[CH3:9][N:7]([CH2:5][C:4]1[CH:3]=[C:2]([NH2:1])[CH:12]=[C:11]([C:13]([F:16])([F:14])[F:15])[CH:10]=1)[CH3:8]3-Amino-N,N-dimethyl-5-trifluoromethyl-benzamide (2.0 g; 8.6 mmol) dissolved in THF (20 ml) is reduced with a 1 M solution of BH3.THF (26 ml) as described in Stage 134.1, yielding the title compound: MS: [M+1]+=219.
Loading…